RESUMEN
The aim of this study was to determine the body mass index (BMI) for the best fitness and effective exercise. This study analyzed data from the Korean national fitness assessment by the Korea Institute of Sport Science (2017). The fitness tests considered were sit-up, standing long jump (SLJ), 20-m multi-stage shuttle run (20-m MSSR), and 10-m shuttle run (10-m SR) tests. The BMIs for the best fitness and widths of the fitness distributions were calculated using the lump mean value and Gaussian fitting. The values of BMI (kg/m2) associated with the best sit-up, SLJ, 20-m MSSR, and 10-m SR scores were 23.4, 22.6, 22.2, and 22.6 for males and 19.0, 18.5, 18.6, and 18.6 for females. The widths (kg/m2) of the sit-up, SLJ, 20-m MSSR, and 10-m SR distributions were 3.65, 3.42, 3.73, and 2.86 for males and 4.84, 4.88, 4.45, and 4.35 for females. The results show that the BMI can be reduced the most and fitness can be increased effectively by the 20-m MSSR for males and the SLJ for females, which could be used to establish personal exercise aims.
Asunto(s)
Índice de Masa Corporal , Ejercicio Físico , Aptitud Física , Adulto , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Distribución Normal , República de Corea/epidemiología , Factores Sexuales , Adulto JovenRESUMEN
BACKGROUND: Optimal medical therapy and the management of cardiac risk factors are crucial for the secondary prevention of acute coronary syndrome (ACS). However, there have been reports on the underutilization of secondary-prevention medications for ACS. This study aimed to investigate adherence of in-hospital prescriptions to clinical practice guidelines for the secondary prevention of ACS using real-world data. MATERIALS AND METHODS: We collected information on ACS patients from national insurance claims data. The in-hospital prescriptions of secondary-prevention medications for post-ACS patients were analyzed. Prescription patterns were analyzed in relation to demographic, clinical, and institutional features. The utilization of five recommended medications and the factors influencing their use were investigated using logistic regression analysis. RESULTS: In total, 1,983 ACS patients were included in this analysis. The prescription rates of secondary-prevention medications were 94.4% for aspirin, 96.1% for P2Y12 inhibitors, 67.4% for ß-blockers, 63.5% for ACE inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), and 86.5% for statins. Less than half of the patients were prescribed all five recommended medications. The prescription rate of secondary-prevention medications was lower in patients with unstable angina than in patients with myocardial infarction, particularly for ß-blockers and ACEIs/ARBs. The best predictive variable for determining the use of all five recommended medications was the type of ACS according to the results of the logistic regression analysis. CONCLUSIONS: In Korea, there is room for improvement in the prescription rates of secondary-prevention medications in post-ACS patients, particularly for ß-blockers and ACEIs/ARBs.â©.